AIDS was first recognized in 1981. In 1983 the causal virus was identified. Initially the main concern of the health sector was with ‘high risk’ groups in the west: hemophiliacs, drug users and gay men. It soon became apparent that the disease had the potential to spread further, but by 2000 it was recognized it was not going to be a threat to the majority of people in these areas, and indeed transmission could be prevented.
The World Health Organization (WHO) has recommended scaling up access to testing and treatment for TB infection, especially among groups who are particularly at risk, such as small children and people living with HIV. The move will expand testing and care for people with latent TB infection. Precisely what the implications of the new guidelines are for the Global Fund is not yet known.
In operationalizing its strategic initiatives, the Secretariat has ensured that each initiative has a “sharp focus” on deliverables and outcomes, with strong accountability for delivery, a spokesperson for the Secretariat says.
The Global Fund, the World Health Organization (WHO), the Stop TB Partnership and 13 countries with a high burden of TB have launched a program to find and treat an additional 1.5 million missing cases of TB by the end of 2019.
A new database is being developed in Eastern Europe and Central Asia (EECA) containing information on antiretrovirals (ARVs) in use in 15 countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Poland, the Russian Federation, Tajikistan, Ukraine and Uzbekistan.
AHF and researchers call for more transparency in UNAIDS’ estimates of the numbers of people on ARVs
The AIDS Healthcare Foundation (AHF), a Los Angeles-based AIDS service and activist organization with a global reach, has called for more transparency and accountability in the way UNAIDS estimates the number of people living with HIV/AIDS who are on life-saving antiretroviral treatment.
Global Fund has no immediate plans to promote the inclusion of the new malaria vaccine in the programs it supports
For now, the Global Fund has no plans to promote the inclusion of the new malaria vaccine, “RTS,S”, into the malaria programming it supports. Although the vaccine shows promise, there are concerns about how it can be effectively administered.
At Financing for Development conference, the outlines of a plan to fund the post-2015 development agenda
A high-level meeting of global stakeholders took place 13-16 July in Addis Ababa to develop a strategy to finance the post-2015 sustainable development goals, against a backdrop of donor fatigue, the enduring global financial crisis and a growing insistence on improved domestic financing for development issues.